HIV News and Research

RSS

Zambia, Zimbabwe address TB/HIV co-infection

The Center for Global Health Policy's "Science Speaks" blog outlines efforts to fight TB/HIV co-infection in Zambia and Zimbabwe.

18 Apr 2013

Study shows association between physical activity, reduced mortality among breast cancer survivors

Breast cancer survivors are among the women who could most benefit from regular physical activity, yet few meet national exercise recommendations during the 10 years after being diagnosed, according to a study by researchers at Fred Hutchinson Cancer Research Center.

18 Apr 2013

Research findings could lead to novel approaches for eliminating reservoirs of HIV-1

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered how the protein that blocks HIV-1 from multiplying in white blood cells is regulated.

18 Apr 2013

Tacere Therapeutics submits TT-034 clinical trial application to Recombinant DNA Advisory Committee

RNAi-based therapeutics company Benitec Biopharma Limited today announced that the company's wholly owned US subsidiary, Tacere Therapeutics Inc., has submitted an application to the US National Institutes of Health's Recombinant DNA Advisory Committee.

18 Apr 2013

Registration open for 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention

Registration for the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) -- which will take place in Kuala Lumpur, Malaysia, from June 30 to July 3, 2013 -- is now open through the conference webpage, which notes "[d]elegates are encouraged to register by 18 April 2013 ... to avoid the late fee surcharge, which begins on 19 April."

17 Apr 2013

Regional meeting to scale up collaborative TB/HIV activities begins in Maputo

"The regional meeting to scale up collaborative TB/HIV activities in Africa kicked off in Maputo last week with presentations scheduled for 14 African country representatives to share progress and challenges in confronting TB/HIV co-infection in the most highly impacted region of the world," the Center for Global Health Policy's "Science Speaks" blog reports.

17 Apr 2013

Antiretroviral therapy does not affect resting energy expenditure in HIV-infected women

Studies have shown that about 10 percent of men infected with human immunodeficiency virus have an elevated resting energy expenditure.

17 Apr 2013

Circumcision offers men some protection against HIV, discovers TGen-led study

Male circumcision reduces the abundance of bacteria living on the penis and might help explain why circumcision offers men some protection against HIV, according to a study led by the Translational Genomics Research Institute.

17 Apr 2013

Adult male circumcision reduces bacteria living on penis, study shows

Circumcision drastically alters the microbiome of the penis, changes that could explain why circumcision offers protection against HIV and other viral infections.

17 Apr 2013

First Edition: April 16, 2013

Today's headlines include coverage of the Supreme Court oral arguments regarding whether patents should be granted for human genes.

16 Apr 2013

IRIN examines how mining industry in Mozambique increasing fears of HIV

IRIN examines how "[e]very mining boom brings the fear of a rising HIV infection rate, particularly in a country like Mozambique, where the estimated prevalence is already 11.3 percent."

16 Apr 2013

Global Fund has achieved impressive results, but more work remains

"This week I had the pleasure to host a preparatory meeting between donors of the Global Fund to Fight AIDS, Tuberculosis and Malaria," European Commissioner for Development Andris Piebalgs writes in the Huffington Post's "The Big Push" blog.

16 Apr 2013

Pneumococcal vaccine: an interview with Graham Clarke, CEO ImmBio

The pathogen that we are talking about is called streptococcus pneumoniae. That is a fairly common bacteria and if you did a nasal swab you would find that quite a lot of people have this bacterium living in their nasal passages.

16 Apr 2013

Benitec to conduct phase I/II clinical trial of TT-034 in patients with HCV in UCSD site

RNAi-based therapeutics company Benitec Biopharma Limited today announced the selection of the University of California, San Diego, Health Sciences as the second site for its upcoming phase I/II first-in-man trial for TT-034 in Hepatitis C infections.

16 Apr 2013

Study shows mathematical models can help assess effectiveness of HIV intervention combinations

South Africa is home to the largest HIV epidemic in the world with a total of 5.6 million people living with HIV. Large-scale clinical trials evaluating combination methods of prevention and treatment are often prohibitively expensive and take years to complete.

16 Apr 2013

Global commitment needed for polio eradication

"I have spent my career seeking to understand and tackling deadly viruses, from ebola to HIV. But polio stands out because, unlike these diseases, we already hold the key to its eradication: effective vaccines," Peter Piot, director and professor of global health at the London School of Hygiene and Tropical Medicine, writes in The Guardian's "Poverty Matters" blog.

15 Apr 2013

Malaria control strategies must adapt to rapidly changing patterns of infection

Malaria control strategies must keep up with the rapidly changing patterns of malaria infection in low transmission settings, according to the authors of a new Review, published in The Lancet. Whereas women and young children suffer from the greatest burden of malaria in high transmission areas, an increasing proportion of malaria cases in low transmission settings are occurring in adult men, sometimes concentrated in small geographic areas and sharing certain occupations or behaviours.

15 Apr 2013

Study: Certain types of papilloma virus might prevent cervical cancer

There are over 100 different types of human papilloma virus (HPV). Cervical cancer is known to be caused by infection with approximately 14 so-called "high-risk" types of this virus.

From The University of Manchester 12 Apr 2013

New approaches to treat persistent viral infections like HIV and hepatitis C

UCLA scientists have shown that temporarily blocking a protein critical to immune response actually helps the body clear itself of chronic infection. Published in the April 12 edition of Science, the finding suggests new approaches to treating persistent viral infections like HIV and hepatitis C.

12 Apr 2013

Tailoring national HIV programs to better meet people's needs

"The features of the global HIV epidemic vary by country, often by community and patient, and it's important to understand these distinctions so that we can design programs to meet people's needs and strengthen their access to treatment and prevention," Bill Gates, co-chair of the Bill & Melinda Gates Foundation, writes in the foundation's "Impatient Optimists" blog.

12 Apr 2013